Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Pluri Inc PLUR

Pluri Inc., formerly known as Pluristem Therapeutics Inc., is an Israel-headquartered company engaged in the research and provision of cell-based products directed for a range of industries. The Company is focused on researching and developing cell transformation and 3D cell expansion technologies that allow mass production of cells. The products of the Company are used for the pharmaceutical industry as well as for food technology, agriculture technology, and cell-based materials. In the pharmaceutical sector, the Company's preclinical and clinical programs explore multiple therapeutic areas such as vascular disease, inflammation-related conditions, muscle injuries, and hematological disorders. In the food sector, the Firm produces cultivated meat, cultivated fish, and seafood, as well as plant-based products. In agriculture, the Company develops alternative farming methods. The Company has a portfolio of over 140 granted patents in approximately 52 countries.


NDAQ:PLUR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by lucaM1on Apr 17, 2022 10:53am
113 Views
Post# 34608343

A New Cultured Meat report

A New Cultured Meat report

A New Cultured Meat report was released by visualcapitalist.com. 

The report, in part, talks about the big financial potential of this up-and-coming industry: "Depending on factors such as strong consumer demand, price parity, and innovation in cellular agriculture, the cultured meat market could explode within the next decade and be worth $25 billion by 2030 according to McKinsey.

Interestingly, the success of the cultured meat market will also bleed into other adjacent industries such as dairy, eggs, seafood, chocolate, and honey."

Companies like Pluristem (NASDAQ:$PSTI) who are establishing themselves as a leading player in the early stages of the industry could see amazing growth in the upcoming years. 

<< Previous
Bullboard Posts
Next >>